About Song Li
Song Li is a co-founder and director at Duo Oncology.
Form D filings also name Song Li as an executive officer, director and promoter at SirnaMed Therapeutics.
Song Li first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Song Li in the role, so the role may have started earlier or lasted longer.
Duo Oncology Inc.
Co-Founder and director
2021 – 2026 · Pittsburgh, PA
Develops combination chemotherapy medicines for people with cancer.
Key Colleagues at Startups
The people Song Li works with at each company, as listed on that company's latest Form D.
Duo Oncology Inc. · Form D/A, Aug 7, 2026
JH
Jing-Zhou Hou
Co-Founder and director
Sam Rothstein
CEO & Cofounder, director
ST
Stephen Thorne
Executive officer and promoter
Victoria Manax
Medical Officer and director
Stanley Marks
Board Chairman
Katherine Eichinger
Chief Operating Officer
Joe Gatto
Director
LL
Lusong Luo
Member - BeOne Medicines and director
SirnaMed Therapeutics Inc. · Form D, Jul 25, 2024